36784 Federal Register / Vol. 78, No. 118 / Wednesday, June 19, 2013 / Notices 

of informed consent issues in cluster 

randomized trials. After lunch, there 

will be a special expert panel discussing 

Certificates of Confidentiality (COCs). 

Following opening remarks on the 

morning of July 11, the Subpart A 

Subcommittee (SAS) will give their 

report. This will be followed by a 

discussion of the concept of engagement 

in human subjects research. SAS is 

charged with developing 

recommendations for consideration by 

SACHRP regarding the application of 

subpart A of 45 CFR part 46 in the 

current research environment; this 

Subcommittee was established by 

SACHRP in October 2006. The day will 

conclude with a panel discussion of 

issues surrounding electronic informed 

consent. 

Public attendance at the meeting is 

limited to space available. Individuals 

who plan to attend the meeting and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the designated contact persons. 

Members of the public will have the 

opportunity to provide comments on 

both days of the meeting. Public 

comment will be limited to five minutes 

per speaker. Any members of the public 

who wish to have printed materials 

distributed to SACHRP members for this 

scheduled meeting should submit 

materials to the Executive Director, 

SACHRP, prior to the close of business 

July 5, 2013. 

Dated: June 12, 2013. 

Jerry Menikoff, 

Director, Office for Human Research 

Protections, Executive Secretary, Secretary’s 

Advisory Committee on Human Research 

Protections. 

[FR Doc. 2013–14518 Filed 6–18–13; 8:45 am] 

BILLING CODE 4150–36–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention (CDC) 

[CDC–2013–0010, Docket Number NIOSH– 

265] 

Survey of Nanomaterial Risk 

Management Practices 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC), 

Department of Health and Human 

Services (HHS). 

ACTION: Proposed NIOSH Survey of 

Nanomaterial Risk Management 

Practices; Notice of Public Meeting and 

Request for Comments. 

SUMMARY: The National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC) 

announces a public meeting and 

opportunity for comment on a proposed 

NIOSH survey. The primary purpose of 

the survey is to evaluate the use of 

NIOSH guidelines and risk mitigation 

practices for safe handling of engineered 

nanomaterials (ENMs) in the workplace. 

Information collected from the survey 

will be useful in future revisions of the 

guidelines. The public is invited to 

comment on the proposed survey 

through a public docket and/or 

participation in a one-day public 

meeting. 

To view the notice and related 

materials, visit http:// 

www.regulations.gov and enter CDC– 

2013–0010 in the search field and click 

‘‘Search.’’ 

Public comment period: Submit either 

electronic or written comments by 

September 15, 2013. 

Registration to attend the meeting 

must be received by July 17, 2013 and 

will be accepted on a first come first 

served basis. See the SUPPLEMENTARY

INFORMATION section for information on 

how to register for the meeting. 

ADDRESSES: The public meeting will be 

held at the NIOSH Alice Hamilton 

building, 5555 Ridge Avenue, 

Cincinnati, OH 45213. The public 

meeting will be held on July 31, 2013, 

from 8 a.m. to 3:00 p.m. EDT. 

Security Considerations: Due to 

mandatory security clearance 

procedures at the NIOSH Alice 

Hamilton building, in-person attendees 

must present valid government-issued 

picture identification to security 

personnel upon entering the parking lot. 

Non-U.S. citizens: Because of CDC 

Security Regulations, any non-U.S. 

citizen wishing to attend this meeting 

must provide the following information 

in writing to the NIOSH Docket Officer 

at the address below no later than June 

29, 2013 to allow time for mandatory 

CDC facility security clearance 

procedures to be completed. 

1. Name: 

2. Gender: 

3. Date of Birth: 

4. Place of birth (city, province, state, 

country): 

5. Citizenship: 

6. Passport Number: 

7. Date of Passport Issue: 

8. Date of Passport Expiration: 

9. Type of Visa: 

10. U.S. Naturalization Number (if a 

naturalized citizen): 

11. U.S. Naturalization Date (if a 

naturalized citizen): 

12. Visitor’s Organization: 

13. Organization Address: 

14. Organization Telephone Number: 

15. Visitor’s Position/Title within the 

Organization: 

This information will be transmitted 

to the CDC Security Office for approval. 

Visitors will be notified as soon as 

approval has been obtained. 

You may submit comments, identified 

by CDC–2013–0010 and Docket Number 

NIOSH–265, by either of the following 

two methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: NIOSH Docket Office, Robert 

A. Taft Laboratories, 4676 Columbia 

Parkway, MS C–34, Cincinnati, Ohio 

45226. 

Instructions: All information received 

in response to this notice must include 

the agency name and docket number 

(CDC–2013–0010; NIOSH–265). All 

relevant comments received will be 

posted without change to http:// 

www.regulations.gov, including any 

personal information provided. All 

electronic comments should be 

formatted as Microsoft Word. Please 

make reference to CDC–2013–0010 and 

Docket Number NIOSH–265. 

SUPPLEMENTARY INFORMATION: 

Attendance: The meeting is open to the 

public, limited only by the capacity (80) 

of the conference room. Confirm your 

attendance to this meeting by sending 

an email to jun1@cdc.gov by July 17, 

2013. An email confirming registration 

will be sent from NIOSH and will 

include details needed to participate. 

Oral comments given at the meeting will 

be recorded and included in the NIOSH 

Docket Number 265. 

Background: NIOSH is among the 

world’s leaders in promoting the safe 

and responsible development and use of 

ENMs. NIOSH has published guidelines 

on the safe use of ENMs including 

‘‘Approaches to Safe Nanotechnology: 

Managing the Health and Safety 

Concerns Associated with Engineered 

Nanomaterials’’ (http://www.cdc.gov/ 

niosh/docs/2009–125/pdfs/2009– 

125.pdf) and ‘‘General Safe Practices for 

Working With Engineered 

Nanomaterials in Research 

Laboratories’’ (http://www.cdc.gov/ 

niosh/docs/2012–147/pdfs/2012– 

147.pdf). Other organizations in the U.S. 

and around the world have also 

developed guidelines for the safe use of 

ENMs. The proposed survey will 

examine the extent to which these and 

other guidelines are implemented and 

the barriers to using the guidelines. 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 78, No. 118 / Wednesday, June 19, 2013 / Notices 36785 

A draft questionnaire is available for 

review at http://www.regulations.gov. 

NIOSH requests public input on the 

content of the questionnaire and 

consideration of the following: 

(1) Apart from a survey, what 

alternative methods should be 

considered to gather this information? 

(2) What resources are available that 

can be used to identify nanomaterial 

producers, distributors, end-users, and 

R&D laboratories for inclusion in a 

sampling frame? 

(3) A web-based survey is being 

proposed primarily because it is costefficient and can be easy to administer. 

Should any other modes (telephone, 

mail) be considered? 

(4) In small and medium-sized 

establishments, who would be the 

person best suited to respond to 

questions addressing risk management 

practices for ENMs? 

(5) What should be the maximum 

amount of time needed to complete the 

survey? 

(6) Is benchmarking adherence to safe 

use guidelines of value to your 

organization? 

(7) What guidelines are being used by 

your organization to minimize worker 

exposure to ENMs? 

(8) Are there any questions in the 

draft survey that should be excluded? 

Are there any questions not included in 

the draft survey that should be 

included? 

FOR FURTHER INFORMATION CONTACT: Jim 

Boiano—jboiano@cdc.gov; 513–841– 

4246 or Rebecca Tsai—rtsai@cdc.gov; 

513–841–4398, NIOSH, 4676 Columbia 

Parkway, Mail Stop R17, Cincinnati, 

Ohio 45226–1998. 

Dated: June 13, 2013. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health, Centers for Disease Control 

and Prevention. 

[FR Doc. 2013–14564 Filed 6–18–13; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

The meeting announced below 

concerns Centers for Disease Control 

and Prevention Public Health 

Preparedness and Response Research to 

Aid Recovery from Hurricane Sandy, 

Request for Application (RFA) TP13– 

001, initial review. 

Correction: The notice was published 

in the Federal Register on June 11, 

2013, Volume 78, Number 112, Pages 

35035—35036. The time, date and place 

should read as follows: 

Time and Date: 12:00 p.m.–5:00 p.m. 

(EST), July 10, 2013 (Closed). 

Place: Teleconference. 

Contact Person for More Information: 

Shoukat Qari, D.V.M., Ph.D., Scientific 

Review Officer, CDC, 1600 Clifton Road, 

NE., Mailstop K72, Atlanta, Georgia 

30333, Telephone: (770) 488–8808. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dana Redford, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2013–14541 Filed 6–18–13; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: National Medical Support 

Notice 

OMB No.: 0970–0222 

Description: The National Medical 

Support Notice (NMSN) is a two-part 

document that requires information 

from State child support enforcement 

agencies, employers, and health plan 

administrators to assist in enforcing 

health care coverage provisions in a 

child support order. The Department of 

Health and Human Services (DHHS), 

Administration for Children and 

Families (ACF) developed and 

maintains Part A of the NMSN, which 

is sent to an obligor’s employer for 

completion; the Department of Labor 

(DOL) developed and maintains Part B 

of the NMSN, which is provided to 

health care administrators following 

completion of Part A. 

DOL revised Part B to conform with 

changes to the currently approved Part 

A and is seeking a three year approval 

from OMB. To avoid burdening the 

State child support enforcement 

agencies with potential reprogramming 

at varying times due to future changes 

in either Part A or Part B, ACF is 

resubmitting an unchanged information 

collection package and requesting an 

extension to the current OMB approval 

of NMSN Part A to synchronize the 

expiration date with NMSN Part B. 

Respondents: State child support 

enforcement agencies, employers, and 

health plan administrators. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per response 

Total burden 

hours 

National Medical Support Notice—Part A—Notice To Withhold for Health 

Care Coverage ............................................................................................. 54 97,775 0.17 897,574.50 

Estimated Total Annual Burden 

Hours: 897,574.50. 

Additional Information: 

Copies of the proposed collection may 

be obtained by writing to the 

Administration for Children and 

Families, Office of Planning, Research 

and Evaluation, 370 L’Enfant 

Promenade, SW., Washington, DC 

20447, Attn: ACF Reports Clearance 

Officer. All requests should be 

identified by the title of the information 

collection. Email address: 

infocollection@acf.hhs.gov. 

OMB Comment: 

OMB is required to make a decision 

concerning the collection of information 

between 30 and 60 days after 

publication of this document in the 

Federal Register. Therefore, a comment 

is best assured of having its full effect 

mstockstill on DSK4VPTVN1PROD with NOTICES